Multicenter study confirms low testosterone in 84 percent of lung cancer patients taking crizotinib
A previous study by the University of Colorado Cancer Center reported the common side effect of low testosterone in men treated with the recently approved lung cancer agent, crizotinib. A new study published this week in ...
Apr 16, 2013
0
0